Graybug Vision announces pipeline expansion – Tips & Results
Graybug Vision Inc. today announced a strategic update on its pipeline programs GB-102 in wet age-related macular degeneration (wet AMD), GB-401 in primary open-angle glaucoma (POAG), as well as its newly acquired assets in corneal disease (GB-501 ), inherited retinal disorders (GB-601), and geographic atrophy (GB-701). “We are very pleased to advance GB-102 into a … Read more